Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quoted Sales & Earnings Commercial

QUOTED. 2 August 2019. Bryan Hanson.

  • News

Executive Summary

Zimmer Biomet says its long-term plan to return to steady growth is ahead of schedule. See what company CEO Bryan Hanson said about it here.

“We’ve increased accountability and strengthened our ‘ZB spirit’ across the organization as a result of our new structure, new leadership team and through a relentless focus on culture in connection to our mission. We continue to drive efficiency throughout our supply chain to ensure that we meet increased demand for our products and drive confidence in our sales team.” – Bryan Hanson, CEO, Zimmer Biomet Holdings Inc.

Click here for a free trial of Medtech Insight

 
Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Quoted Sales & Earnings Commercial
Latest Headlines

Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel

Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs

More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

See All
UsernamePublicRestriction

Register

MT125449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By